Avalo Therapeutics Inc (AVTX)
9.64
-0.75
(-7.22%)
USD |
NASDAQ |
May 16, 16:00
9.92
+0.28
(+2.90%)
After-Hours: 20:00
Avalo Therapeutics Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.038M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.544M |
| March 31, 2022 | 0.938M |
| December 31, 2021 | 1.06M |
| September 30, 2021 | 1.435M |
| June 30, 2021 | 4.12M |
| March 31, 2021 | 3.13M |
| December 31, 2020 | 2.177M |
| September 30, 2020 | 1.671M |
| June 30, 2020 | 2.032M |
| March 31, 2020 | 2.195M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.002M |
| September 30, 2019 | 4.956M |
| June 30, 2019 | 2.860M |
| March 31, 2019 | 2.718M |
| December 31, 2018 | 0.8223M |
| September 30, 2018 | 3.008M |
| June 30, 2018 | 3.308M |
| March 31, 2018 | 2.830M |
| December 31, 2017 | 2.935M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.1325M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2022
4.956M
Maximum
Sep 2019
1.877M
Average
1.671M
Median
Sep 2020
Accounts Receivable (Quarterly) Benchmarks
| Imunon Inc | -- |
| iBio Inc | -- |
| Kodiak Sciences Inc | -- |
| Petros Pharmaceuticals Inc | 2.226M |
| Ocugen Inc | -- |